Vliyanie sulodeksida na funktsional'noe sostoyanie endoteliya u bol'nykh s sakharnym diabetom i diabeticheskoyretinopatiey

Aim. To study effect of sulodexide (Vessel Due F) on the functional state of endothelium in patients with diabetic retinopathy. Materials and methods. A total of 37 patients with DR were divided in 2 groups and treated with sulodexide. Group 1 comprised 16 patients withnon-proliferative DR, group...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Natalya Alexandrovna Gavrilova, Olga Evgen'evna Tishchenko
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2011
Materias:
Acceso en línea:https://doaj.org/article/763d89d135374d0196595cb522d8e73e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:763d89d135374d0196595cb522d8e73e
record_format dspace
spelling oai:doaj.org-article:763d89d135374d0196595cb522d8e73e2021-11-14T09:00:16ZVliyanie sulodeksida na funktsional'noe sostoyanie endoteliya u bol'nykh s sakharnym diabetom i diabeticheskoyretinopatiey2072-03512072-037810.14341/2072-0351-5637https://doaj.org/article/763d89d135374d0196595cb522d8e73e2011-06-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/5637https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Aim. To study effect of sulodexide (Vessel Due F) on the functional state of endothelium in patients with diabetic retinopathy. Materials and methods. A total of 37 patients with DR were divided in 2 groups and treated with sulodexide. Group 1 comprised 16 patients withnon-proliferative DR, group 2 included 21 patients with preproliferative DR. The functional state of endothelium was estimated from the plasma andserum levels of endothelial factors (sVCAM, endothelin, nitric oxide, t-PA, Willebrand factor). Results. The measurement of the initial levels of endothelial factors in both groups revealed significant changes in endothelin, nitric oxide, and sVCAMsuggesting disturbances of endothelial function due to DR. Sulodexide therapy normalized it regardless of DR stage and thereby improved functionalactivity of retina. Conclusion. This study has demonstrated beneficial effect of sulodexide on endothelial function in patients with DR due to correction of the productionof vasoactive factors (endothelin, nitric oxide) and stimulation of fibrinolytic activity of the vascular wall (t-PA).Natalya Alexandrovna GavrilovaOlga Evgen'evna TishchenkoEndocrinology Research Centrearticlediabetic retinopathysulodexideendothelial dysfunctionendothelial factorsNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 14, Iss 2, Pp 66-68 (2011)
institution DOAJ
collection DOAJ
language EN
RU
topic diabetic retinopathy
sulodexide
endothelial dysfunction
endothelial factors
Nutritional diseases. Deficiency diseases
RC620-627
spellingShingle diabetic retinopathy
sulodexide
endothelial dysfunction
endothelial factors
Nutritional diseases. Deficiency diseases
RC620-627
Natalya Alexandrovna Gavrilova
Olga Evgen'evna Tishchenko
Vliyanie sulodeksida na funktsional'noe sostoyanie endoteliya u bol'nykh s sakharnym diabetom i diabeticheskoyretinopatiey
description Aim. To study effect of sulodexide (Vessel Due F) on the functional state of endothelium in patients with diabetic retinopathy. Materials and methods. A total of 37 patients with DR were divided in 2 groups and treated with sulodexide. Group 1 comprised 16 patients withnon-proliferative DR, group 2 included 21 patients with preproliferative DR. The functional state of endothelium was estimated from the plasma andserum levels of endothelial factors (sVCAM, endothelin, nitric oxide, t-PA, Willebrand factor). Results. The measurement of the initial levels of endothelial factors in both groups revealed significant changes in endothelin, nitric oxide, and sVCAMsuggesting disturbances of endothelial function due to DR. Sulodexide therapy normalized it regardless of DR stage and thereby improved functionalactivity of retina. Conclusion. This study has demonstrated beneficial effect of sulodexide on endothelial function in patients with DR due to correction of the productionof vasoactive factors (endothelin, nitric oxide) and stimulation of fibrinolytic activity of the vascular wall (t-PA).
format article
author Natalya Alexandrovna Gavrilova
Olga Evgen'evna Tishchenko
author_facet Natalya Alexandrovna Gavrilova
Olga Evgen'evna Tishchenko
author_sort Natalya Alexandrovna Gavrilova
title Vliyanie sulodeksida na funktsional'noe sostoyanie endoteliya u bol'nykh s sakharnym diabetom i diabeticheskoyretinopatiey
title_short Vliyanie sulodeksida na funktsional'noe sostoyanie endoteliya u bol'nykh s sakharnym diabetom i diabeticheskoyretinopatiey
title_full Vliyanie sulodeksida na funktsional'noe sostoyanie endoteliya u bol'nykh s sakharnym diabetom i diabeticheskoyretinopatiey
title_fullStr Vliyanie sulodeksida na funktsional'noe sostoyanie endoteliya u bol'nykh s sakharnym diabetom i diabeticheskoyretinopatiey
title_full_unstemmed Vliyanie sulodeksida na funktsional'noe sostoyanie endoteliya u bol'nykh s sakharnym diabetom i diabeticheskoyretinopatiey
title_sort vliyanie sulodeksida na funktsional'noe sostoyanie endoteliya u bol'nykh s sakharnym diabetom i diabeticheskoyretinopatiey
publisher Endocrinology Research Centre
publishDate 2011
url https://doaj.org/article/763d89d135374d0196595cb522d8e73e
work_keys_str_mv AT natalyaalexandrovnagavrilova vliyaniesulodeksidanafunktsionalnoesostoyanieendoteliyaubolnykhssakharnymdiabetomidiabeticheskoyretinopatiey
AT olgaevgenevnatishchenko vliyaniesulodeksidanafunktsionalnoesostoyanieendoteliyaubolnykhssakharnymdiabetomidiabeticheskoyretinopatiey
_version_ 1718429587020447744